191 related articles for article (PubMed ID: 24726751)
1. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
Bevier M; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
[TBL] [Abstract][Full Text] [Related]
3. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA
Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
[TBL] [Abstract][Full Text] [Related]
4. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
Shu X; Sundquist K; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
[TBL] [Abstract][Full Text] [Related]
5. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
[TBL] [Abstract][Full Text] [Related]
6. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
Randén M; Rutqvist LE; Johansson H
Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
[TBL] [Abstract][Full Text] [Related]
7. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
8. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal cancer incidence and survival in Scotland, 1975-2001.
Anandan C; Elton R; Hitchings A; Brewster DH
Clin Otolaryngol; 2008 Feb; 33(1):12-7. PubMed ID: 18302545
[TBL] [Abstract][Full Text] [Related]
10. Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012.
Schroten-Loef C; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP
Eur J Cancer; 2018 Sep; 101():77-86. PubMed ID: 30031970
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
12. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Kaposi's sarcoma in Scotland, 1976-1996.
Brewster DH; Harris V; Black RJ; Goldberg DJ
Br J Cancer; 1999 Apr; 79(11-12):1938-42. PubMed ID: 10206318
[TBL] [Abstract][Full Text] [Related]
14. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
15. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities.
Urban D; Rao A; Bressel M; Lawrence YR; Mileshkin L
Br J Cancer; 2013 Sep; 109(5):1318-24. PubMed ID: 23860528
[TBL] [Abstract][Full Text] [Related]
16. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
17. Site-specific survival rates for cancer of unknown primary according to location of metastases.
Hemminki K; Riihimäki M; Sundquist K; Hemminki A
Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
[TBL] [Abstract][Full Text] [Related]
18. Cancer of unknown primary: time trends in incidence, United States.
Mnatsakanyan E; Tung WC; Caine B; Smith-Gagen J
Cancer Causes Control; 2014 Jun; 25(6):747-57. PubMed ID: 24710663
[TBL] [Abstract][Full Text] [Related]
19. Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.
Pavlidis N; Rassy E; Smith-Gagen J
Int J Cancer; 2020 Mar; 146(6):1490-1498. PubMed ID: 31144291
[TBL] [Abstract][Full Text] [Related]
20. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
Brustugun OT; Helland Å
Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
